Adani Group Shares Rally Recouping Nearly 150 Billion in Lost Market Value PostHindenburg ADP Private Payrolls Rise by 109000 in April Beating Expectations Couple Feigns Financial Strain to Maintain Social Circle A Behavioral Finance Perspective 7 Practical Strategies to Reduce Spending on Groceries Bills and Shopping Saudi Arabias Vision 2030 Spending Spree Faces Reality Check as Fiscal Constraints Bite Tony Blairs UK Economic Diagnosis Praised AICentric Prescription Questioned NWS Q1 2026 Earnings EPS Beats Estimates by 12 as Profitability Improves Samsara IOT Q1 2026 Earnings Strong Operating Leverage Drives EPS Beat BHP Q1 2026 Earnings EPS Miss Weighs on Sentiment as Commodity Headwinds Persist Polar Power Inc POLA Q1 2026 Earnings Narrowed Loss and Quiet Revenue Disclosure Lift Shares SkyWater Technology Q1 2026 Earnings EPS Misses Estimates Stock Holds Gains BG Q1 2026 Earnings Strong EPS Surprise as Agribusiness Margins Improve Live Oak Acquisition Corp V LOKV Holds Steady Near Support as Investors Await Development AMN Healthcare AMN Holds Steady Near Key Support as Healthcare Staffing Sector Faces Uncertainty ThredUp Inc TDUP Slips 338 as Broader Market Weakness Weighs on Resale Platform Extreme Networks Dips 130 as Stock Tests Key Support Levels Xtant Medical Holdings Holds Near Key Resistance Level After Modest Gain Concealing Wealth to Fit In The Social Cost of Financial Pretending FTFT Q2 2024 Earnings Narrowing Losses Amidst Strategic Transformation in Blockchain and Fintech Pan American Silver PAAS Advances 219 as Precious Metals Sentiment Strengthens TON Strategy TONX Slips 926 as Bearish Momentum Builds Key Support Holds PTC Therapeutics PTCT Slips 140 as Biotech Sector Faces Selling Pressure Nuveen Core Plus Impact Fund NPCT Holds Steady Near Key Support Levels Inspira Technologies Warrant IINNW Holds Steady at 014 A Quiet Stretch Between Key Levels Wave Life Sciences WVE Holds Near Support After Modest Pullback Check Point Software CHKP Slips as Broader Market Pressures Weigh on Cybersecurity Sector Bolt Biotherapeutics BOLT Slips 12 as Shares Test Key Support at 465